1. Home
  2. SBFM vs HLN Comparison

SBFM vs HLN Comparison

Compare SBFM & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunshine Biopharma Inc.

SBFM

Sunshine Biopharma Inc.

HOLD

Current Price

$1.43

Market Cap

7.2M

Sector

Health Care

ML Signal

HOLD

Logo Haleon plc (Each representing two)

HLN

Haleon plc (Each representing two)

HOLD

Current Price

$9.55

Market Cap

41.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBFM
HLN
Founded
2006
2022
Country
United States
United Kingdom
Employees
52
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.2M
41.7B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SBFM
HLN
Price
$1.43
$9.55
Analyst Decision
Strong Buy
Hold
Analyst Count
1
1
Target Price
$7.00
N/A
AVG Volume (30 Days)
63.5K
10.0M
Earning Date
11-13-2025
07-31-2025
Dividend Yield
N/A
1.91%
EPS Growth
N/A
41.64
EPS
N/A
0.23
Revenue
$37,323,742.00
$15,096,588,575.00
Revenue This Year
$10.26
$1.51
Revenue Next Year
$32.63
$4.67
P/E Ratio
N/A
$41.62
Revenue Growth
13.24
N/A
52 Week Low
$1.17
$8.71
52 Week High
$3.90
$11.42

Technical Indicators

Market Signals
Indicator
SBFM
HLN
Relative Strength Index (RSI) 34.27 49.53
Support Level $1.43 $9.30
Resistance Level $1.49 $9.65
Average True Range (ATR) 0.06 0.14
MACD 0.01 -0.03
Stochastic Oscillator 0.00 35.71

Price Performance

Historical Comparison
SBFM
HLN

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.

About HLN Haleon plc (Each representing two)

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Share on Social Networks: